LOANS for Biomedical Research Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The LOANS for Biomedical Research Act (H.R. 7539) is a legislative proposal introduced in the 118th Congress aimed at providing loan assistance or financial support mechanisms for biomedical research. The bill was referred to the House Subcommittee on Health but did not advance further and ultimately failed or expired. Specific details about the bill's provisions, funding, or implementation are not available in the provided source data.
H.R. 7539 sought to support biomedical research through loan-related measures but did not progress beyond early committee referral and expired without enactment.
- The bill is titled 'LOANS for Biomedical Research Act' and relates to the health policy area.
- It was introduced in the House of Representatives during the 118th Congress.
- The latest recorded action was referral to the Subcommittee on Health on March 8, 2024.
- The bill ultimately failed or expired without further legislative action.
- No official summary or full text is available in the source data.
['Biomedical researchers and institutions involved in biomedical research', 'Potentially federal agencies overseeing health and research funding', 'Health sector stakeholders interested in biomedical innovation']
['Lack of available text and summary limits understanding of specific implementation mechanisms and oversight provisions.', 'Unclear funding sources and financial impact due to absence of detailed bill text.', 'Potential challenges in administering loan programs without explicit authority or enforcement language.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health but did not advance further. Its failure or expiration indicates it did not receive sufficient legislative support or priority to move through the committee or floor stages. The health policy area often involves complex funding and regulatory considerations, which may have influenced its legislative progress.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have increased access to financial resources for biomedical research, potentially accelerating innovation.', 'Loan programs may create administrative burdens for federal agencies tasked with oversight and management.', 'Financial assistance mechanisms might influence the priorities and strategies of biomedical research institutions.']
The absence of the full bill text and official summary limits transparency and public understanding of the bill's provisions and potential impacts. The failure or expiration status suggests limited legislative momentum. Future proposals in this area would benefit from clear, accessible documentation to facilitate oversight and informed public discourse.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.